Table 1 Implications for CKD staging when a Jaffe or a standardized serumcreatinine is used
| Â | Â | MDRD Jaffe p10/ p90 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | <30 ml/min/1.73 m2 | 30-45 ml/min/1.73 m2 | 45-60 ml/min/1.73 m2 | 60-90 ml/min/1.73 m2 | >90 ml/min/1.73 m2 | Total | |||||
| Â | Â | p10 | p90 | p10 | p90 | p10 | p90 | p10 | p90 | p10 | p90 | Â |
MDRD standardized | <30 ml/min/1.73 m2 | 2523 (99.2%) | 2543 (100%) | 20 (0.8%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2543 |
| Â | 30-45 ml/min/1.73 m2 | 0 (0%) | 678 (17.3%) | 3908 (100%) | 3231 (82.7%) | 1 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 3909 |
| Â | 45-60 ml/min/1.73 m2 | 0 (0%) | 0 (0%) | 90 (1.1%) | 3439 (41.9%) | 8126 (98.9%) | 4777 (58.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 8216 |
| Â | 60-90 ml/min/1.73 m2 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 736 (1.8%) | 14598 (36.7%) | 39085 (98.2%) | 25223 (63.3%) | 0 (0%) | (0%) | 39821 |
| Â | >90 ml/min/1.73 m2 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 3448 (12.3%) | 22047 (78.9%) | 24487 (87.7%) | 5888 (21.1%) | 27935 |
| Â | Â | 2523 | 3221 | 4018 | 6670 | 8863 | 19375 | 42533 | 47270 | 24487 | 5888 | 82424 |